Key facts
- Performance.io’s last known valuation is $1.3M (Jun 2019).
- It has raised $80K; the latest was PE Growth/Expansion in May 2025.
- Notable investors include Apiary Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Performance.io
- ·The full record, as it builds
Funding rounds
No funding rounds for Performance.io are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Performance.io
Provider of performance marketing services intended to optimize digital marketing spend for healthcare and pharmaceutical companies. The company provides services that include performance-focused digital marketing strategies that drive organic website traffic and enhance engagement with patients and healthcare professionals, enabling companies to improve the effectiveness of their digital outreach.
- Sector
- Business Products and Services (B2B)
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 68
- Website
- performance-io.com/
- Ownership
- Privately Held (backing)
Performance.io doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Performance.io shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Performance.io in its N-PORT filings yet. We sweep new filings monthly.